Paolo Monini

Dr. Paolo Monini

orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Nature Medicine
Verified
Journal Article
Closed access
CSCecilia Sgadari
Cecilia Sgadari
GBGiovanni Barillari
Giovanni Barillari
ETElena Toschi
Elena Toschi
DCDavide Carlei
Davide Carlei
IBIlaria Bacigalupo
Ilaria Bacigalupo
Barbara EnsoliBarbara Ensoli
Barbara Ensoli

1 July 2001 in European Journal of Cancer
Verified
Journal Article
Closed access
Barbara EnsoliBarbara Ensoli
Barbara Ensoli
CSCecilia Sgadari
Cecilia Sgadari
GBG. Barillari
G. Barillari
MSM.C. Sirianni
M.C. Sirianni
Michael StürzlMichael Stürzl
Michael Stürzl
PMPaolo Monini
Paolo Monini

2 May 1996 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
PMPaolo Monini
Paolo Monini
LLLaura de Lellis
Laura de Lellis
MFMarina Fabris
Marina Fabris
FRFranco Rigolin
Franco Rigolin
ECEnzo Cassai
Enzo Cassai
Sequences of a novel herpesvirus, Kaposi's sarcoma–associated herpesvirus (KSHV), have been identified in Kaposi's sarcoma tissue, but it is not known whether the virus is transmitted by sexual contact.

15 October 2001 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
EGEric Guenzi
Eric Guenzi
KTKristin Töpolt
Kristin Töpolt
ECEmmanuelle Cornali
Emmanuelle Cornali
CLClara Lubeseder‐Martellato
Clara Lubeseder‐Martellato
AJAnita Jörg
Anita Jörg
Michael StürzlMichael Stürzl
Michael Stürzl

20 October 1999 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
Michael StürzlMichael Stürzl
Michael Stürzl
CHChristine Hohenadl
Christine Hohenadl
CZChristian Zietz
Christian Zietz
ECEsmeralda Castanos-Velez
Esmeralda Castanos-Velez
AWAnneliese Wunderlich
Anneliese Wunderlich
Barbara EnsoliBarbara Ensoli
Barbara Ensoli
BACKGROUND: Human herpesvirus 8 (HHV8) infection is associated with all forms of Kaposi's sarcoma (KS). The HHV8 genome locus ORFK13-72-73 (ORF = open reading frame) encodes proteins that may be important in HHV8-mediated pathogenesis, i.e., the latency-associated nuclear antigen (encoded by ORF73), viral-cyc-D (v-cyc-D), a viral homologue of cellular cyclin D (encoded by ORF72), and viral-FLIP (v-FLIP), a homologue of the cellular FLICE (Fas-associated death domain-like interleukin 1 beta-converting enzyme) inhibitory protein (encoded by ORFK13; is an inhibitor of apoptosis [programmed cell death]). Through differential splicing events, this locus expresses individual RNA transcripts that encode all three proteins (tricistronic transcripts) or just two of them (v-FLIP and v-cyc-D; bicistronic transcripts). We examined expression of these transcripts in KS tissues. METHODS: We collected tissues from patients with KS of different stages. By use of an optimized in situ hybridization procedure, we examined different ORFK13-72-73 locus transcripts in HHV8-infected cells in skin lesions and in one adjacent lymph node. Apoptosis in KS lesions was determined by use of an in situ assay. RESULTS AND CONCLUSIONS: Our results indicate the following: 1) Transcripts from the ORFK13-72-73 locus appear to be spliced differentially in latently infected KS cells in skin lesions and in HHV8-infected cells in lymph nodes; specifically, ORFK13-ORF72 bicistronic transcripts were expressed abundantly in KS cells, whereas ORFK13-ORF72-ORF73 tricistronic transcripts were detected only in lymph node cells. 2) Sequences encoding the antiapoptotic protein v-FLIP are expressed at very low levels in early KS lesions, but expression increases dramatically in late-stage lesions. 3) The increase in expression of v-FLIP-encoding transcripts is associated with a reduction in apoptosis in KS lesions. IMPLICATIONS: These data suggest that functional v-FLIP is produced in vivo and that antiapoptotic mechanisms may be involved in the rapid growth of KS lesions, where only a few cells undergoing mitosis are generally observed.

1 September 2003 in The Lancet Oncology
Verified
Journal Article
Closed access
CSCecilia Sgadari
Cecilia Sgadari
PMPaolo Monini
Paolo Monini
GBGiovanni Barillari
Giovanni Barillari
Barbara EnsoliBarbara Ensoli
Barbara Ensoli